Cadila Healthcare is selling 1,25,00,001 equity shares in Bayer Zydus Pharma at a value determined in terms of JVA to Bayer by executing a Share Purchase Agreement (SPA) amongst the company, Bayer and the Joint Venture Company (JVC) - Bayer Zydus Pharma.
Earlier, the company had entered into Joint Venture Agreement (JVA) with Bayer (South East Asia) (Bayer) on January 28, 2011. Both Bayer and the company hold 2.50 crore equity shares of Rs 10 each fully paid-up of Bayer Zydus Pharma.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: